These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8736806)

  • 21. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats.
    Kim EM; O'Hare E; Grace MK; Welch CC; Billington CJ; Levine AS
    Brain Res; 2000 Apr; 862(1-2):11-6. PubMed ID: 10799663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats.
    Stricker-Krongrad A; Kozak R; Burlet C; Nicolas JP; Beck B
    Am J Physiol; 1997 Dec; 273(6):R2112-6. PubMed ID: 9435668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis.
    Tomaszuk A; Simpson C; Williams G
    Horm Res; 1996; 46(2):53-8. PubMed ID: 8871182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The central regulation of energy homeostasis: roles of neuropeptide Y and other brain peptides.
    Bing C; Wang W; Pickavance L; Williams G
    Biochem Soc Trans; 1996 May; 24(2):559-65. PubMed ID: 8736803
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization.
    Currie PJ; Coscina DV
    Brain Res; 1996 Oct; 737(1-2):238-42. PubMed ID: 8930371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain.
    Itateyama E; Chiba S; Sakata T; Yoshimatsu H
    Exp Biol Med (Maywood); 2003 Nov; 228(10):1132-7. PubMed ID: 14610251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
    Parker E; Van Heek M; Stamford A
    Eur J Pharmacol; 2002 Apr; 440(2-3):173-87. PubMed ID: 12007534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats.
    Dryden S; Pickavance L; Frankish HM; Williams G
    Brain Res; 1995 Sep; 690(2):185-8. PubMed ID: 8535835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
    Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
    Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y.
    Rouru J; Pesonen U; Koulu M; Huupponen R; Santti E; Virtanen K; Rouvari T; Jhanwar-Uniyal M
    Eur J Pharmacol; 1995 Jan; 273(1-2):99-106. PubMed ID: 7737322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats.
    Shibasaki T; Oda T; Imaki T; Ling N; Demura H
    Brain Res; 1993 Jan; 601(1-2):313-6. PubMed ID: 7679310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperphagia in obesity is associated with a central peptidergic dysregulation in rats.
    Beck B; Burlet A; Nicolas JP; Burlet C
    J Nutr; 1990 Jul; 120(7):806-11. PubMed ID: 2366113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone.
    Stanley BG; Lanthier D; Chin AS; Leibowitz SF
    Brain Res; 1989 Oct; 501(1):32-6. PubMed ID: 2804697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin.
    Shi Z; Li B; Brooks VL
    Hypertension; 2015 Nov; 66(5):1034-41. PubMed ID: 26370892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic Paraventricular and Arcuate Nuclei Contribute to Elevated Sympathetic Nerve Activity in Pregnant Rats: Roles of Neuropeptide Y and α-Melanocyte-Stimulating Hormone.
    Shi Z; Cassaglia PA; Gotthardt LC; Brooks VL
    Hypertension; 2015 Dec; 66(6):1191-8. PubMed ID: 26483343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in moderate/high fat, high-energy diet-fed mice.
    Zammaretti F; Panzica G; Eva C
    J Physiol; 2007 Sep; 583(Pt 2):445-54. PubMed ID: 17584829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
    Dryden S; Frankish HM; Wang Q; Williams G
    Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
    Sahu A; Dube MG; Phelps CP; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of intrahypothalamic NPY on gastric function.
    Davison JS; Pearce CM
    Proc West Pharmacol Soc; 1997; 40():135-6. PubMed ID: 9436234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.